BSE Live
Oct 17, 10:30Prev. Close
821.75
Open Price
828.95
Bid Price (Qty.)
820.20 (3)
Offer Price (Qty.)
821.40 (40)
NSE Live
Oct 17, 10:30Prev. Close
821.85
Open Price
824.90
Bid Price (Qty.)
820.50 (4)
Offer Price (Qty.)
820.90 (1)
Cash Flow of Natco Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 2,226.00 | 1,555.30 | 770.70 | 155.90 | 392.20 | |
Net CashFlow From Operating Activities | 1,662.00 | 1,196.40 | 784.40 | 57.70 | 183.50 | |
Net Cash Used In Investing Activities | -1,443.90 | -960.50 | -436.60 | -92.50 | -3.20 | |
Net Cash Used From Financing Activities | -212.40 | -237.30 | -346.80 | 35.60 | -183.10 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 5.70 | -1.40 | 1.00 | 0.80 | -2.80 | |
Cash And Cash Equivalents Begin of Year | 5.50 | 6.90 | 5.90 | 5.10 | 7.90 | |
Cash And Cash Equivalents End Of Year | 11.20 | 5.50 | 6.90 | 5.90 | 5.10 |
14.10.2025
Natco Pharma shares fall 3.5% as SC agrees to urgently list Roche's plea on Risdiplam launch
10.10.2025
Natco Pharma shares jump 6% after Delhi HC allows firm to sell 'Risdiplam' in India
10.10.2025
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y
05.06.2025
Natco Pharma Standalone March 2025 Net Sales at Rs 1,157.40 crore, up 19.96% Y-o-Y
03.06.2025
Natco Pharma Consolidated March 2025 Net Sales at Rs 1,221.00 crore, up 14.29% Y-o-Y
28.02.2025
Natco Pharma Consolidated December 2024 Net Sales at Rs 474.80 crore, down 37.41% Y-o-Y